NCT00065767

Data

{
  "briefSummary": "The aim of this study is to determine the effectiveness of treatment with raloxifene, an estrogen-like medication approved by the Food and Drug Administration for the treatment of osteoporosis, in improving memory and the ability to live independently in postmenopausal women with Alzheimer's disease.",
  "completionDate": "2005-03",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 20,
  "enrollmentType": null,
  "nctId": "NCT00065767",
  "phase": "PHASE2, PHASE3",
  "sponsorId": "university-of-wisconsin-madison",
  "startDate": "2001-09",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00065767"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version